BioSyent

BioSyent Market capitalization

The The market capitalization of BioSyent (RX.V) as of Oct 31, 2026 is 175.69 M CAD. In the previous year, The market capitalization was 175.69 M CAD — a change of 0.00% (lower).

Market capitalization

175.69 MCAD

YoY

0.00%

Last updated:

In 2025, BioSyent's market cap stood at 175.69 M CAD, a 0.00% increase from the 175.69 M CAD market cap in the previous year.

The BioSyent Market capitalization history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Market capitalization
Date
Market capitalization
Jan 1, 2018
175.69 M CAD
Jan 1, 2019
175.69 M CAD
Jan 1, 2020
175.69 M CAD
Jan 1, 2021
175.69 M CAD
Jan 1, 2022
175.69 M CAD
Jan 1, 2023
175.69 M CAD
Jan 1, 2024
175.69 M CAD
Jan 1, 2025
175.69 M CAD
The BioSyent Market capitalization history
YEARMarket capitalizationYoY
175.69 MCAD0.00%
175.69 MCAD0.00%
175.69 MCAD0.00%
175.69 MCAD0.00%
175.69 MCAD0.00%
175.69 MCAD0.00%
175.69 MCAD0.00%
175.69 MCAD0.00%
175.69 MCAD0.00%
175.69 MCAD0.00%
175.69 MCAD0.00%
175.69 MCAD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

BioSyent Stock analysis

What does BioSyent do? Biosyent Inc is a Canadian pharmaceutical company founded in 2004. The company's headquarters are located in Mississauga, Ontario. Biosyent is listed on the Toronto Stock Exchange and has a market capitalization of approximately 140 million Canadian dollars. The company's business model is based on acquiring domestic pharmaceutical and nutraceutical products and marketing them in Canada. Biosyent operates in two main divisions: Pharma and Nutraceuticals. The Pharma division includes products such as RepaGyn, a vaginal gel for treating dryness and irritation during menopause, as well as the antiemetic Setofilm/Tablets for the prevention and treatment of nausea and vomiting. The Nutraceutical division includes products such as FeraMAX, a supplement that increases iron in the diet and helps prevent the development of anemia. Biosyent also offers vitamin-rich dietary supplements such as Aerobic Oxygen and Calm Biotic, targeting health-conscious customers. Another important area of Biosyent is Hospital Specialty Pharmaceuticals, targeting hospitals and healthcare facilities. This includes products like Cysview and Cysview Kit, used to detect non-muscle invasive bladder cancer and improve fluorescence during cystoscopy. Biosyent also offers infusion sets designed for intravenous medication administration. Overall, Biosyent has more than 20 products in various categories including women's and men's health, ophthalmology, immunology, and oncology. Over the years, Biosyent Inc has received various awards for its products and business practices. In 2012, the company received the Bio-Wellness Award for its flagship product, RepaGyn. While Biosyent has ambitions to expand its presence in international markets, the company remains primarily focused on the Canadian market. Biosyent relies mainly on a low-cost marketing strategy that aims to directly target patients in order to market its products in a simple way. Overall, Biosyent has a strong market position in Canada and a portfolio of well-established products. The company has a successful history and appears ready for the future with a strong pipeline and a growing presence in the Canadian market. BioSyent is one of the most popular companies on Eulerpool.

Market capitalization Details

Exploring BioSyent's Market Capitalization

BioSyent's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.

Year-to-Year Comparison

A yearly comparison of BioSyent's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.

Impact on Investments

BioSyent's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.

Interpreting Market Capitalization Fluctuations

Variations in BioSyent’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.

Frequently Asked Questions about BioSyent stock

The market capitalization of BioSyent is 175.69 M CAD in 2025.

The market capitalization of BioSyent changed from 175.69 M CAD to 175.69 M CAD, representing a 0.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The market capitalization BioSyent since 2006 – with annual values, charts, and detailed analysis.

Market capitalization (German: Market capitalization, English: market capitalisation or market cap) is the calculated total value of all shares of a publicly traded company. The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company. It is determined by the supply and demand for the company's shares. Thus, market capitalization is significantly influenced by expectations in the stock market regarding the future earnings power of the company and, therefore, can be subject to significant fluctuations.

Number of shares * share price = market capitalization

To evaluate The market capitalization's CAD, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for The market capitalization.

A 'good' CAD varies by industry and company stage. On Eulerpool, you can compare The market capitalization's BioSyent with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — BioSyent

All Key Metrics — BioSyent